Atypical uptake of 99m Tc-HMDP in a patient with metastatic liver disease

Rev Esp Med Nucl Imagen Mol. 2012 Nov-Dec;31(6):350-1. doi: 10.1016/j.remn.2011.11.012. Epub 2012 May 6.

[Article in English, Spanish]

Authors

P Moya Espinosa¹, T Amrani Raissouni, E Ramos Moreno, M D Martínez del Valle Torres, S J Ortega Lozano, J M Jiménez-Hoyuela García

Affiliation

¹ Servicio de Medicina Nuclear, Hospital Universitario Virgen de la Victoria, Málaga, Málaga, Spain.

PMID: 23169390
DOI: 10.1016/j.remn.2011.11.012

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Biomarkers, Tumor / analysis
Bone Neoplasms / diagnostic imaging
Bone Neoplasms / secondary
Carcinoma / diagnostic imaging*
Carcinoma / secondary
Carcinoma, Bronchogenic / chemistry
Female
Hepatomegaly / diagnostic imaging
Hepatomegaly / etiology
Humans
Liver Neoplasms / chemistry
Liver Neoplasms / diagnostic imaging
Liver Neoplasms / secondary*
Neoplasms, Unknown Primary
Neoplastic Cells, Circulating
Neuroendocrine Tumors / chemistry
Peritoneal Neoplasms / diagnostic imaging
Peritoneal Neoplasms / secondary
Radionuclide Imaging
Radiopharmaceuticals / pharmacokinetics*
Technetium Tc 99m Medronate / analogs & derivatives*
Technetium Tc 99m Medronate / pharmacokinetics

Substances

Biomarkers, Tumor
Radiopharmaceuticals
technetium Tc 99m hydroxymethylene diphosphonate
Technetium Tc 99m Medronate